BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 7843912)

  • 41. Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma.
    Jones NM; Yang H; Zhang Q; Morales-Tirado VM; Grossniklaus HE
    BMC Cancer; 2019 May; 19(1):484. PubMed ID: 31117965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.
    Maio M; Altomonte M; Tatake R; Zeff RA; Ferrone S
    J Clin Invest; 1991 Jul; 88(1):282-9. PubMed ID: 1905328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism.
    Yang H; Brackett CM; Morales-Tirado VM; Li Z; Zhang Q; Wilson MW; Benjamin C; Harris W; Waller EK; Gudkov AV; Burdelya LG; Grossniklaus HE
    Oncotarget; 2016 Jan; 7(3):2936-50. PubMed ID: 26655090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunoregulation of intraocular tumours.
    Niederkorn JY
    Eye (Lond); 1997; 11 ( Pt 2)():249-54. PubMed ID: 9349421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal.
    Menier C; Riteau B; Carosella ED; Rouas-Freiss N
    Int J Cancer; 2002 Jul; 100(1):63-70. PubMed ID: 12115588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
    Yamasaki T; Moritake K; Klein G
    J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Target-cell sensitivity to natural killer-cell lysis is determined by the expression of a novel antigen in conjunction with major histocompatibility complex class-I molecules.
    Harris DT; Jaso-Friedmann L; Evans DL
    Scand J Immunol; 1994 Jan; 39(1):73-8. PubMed ID: 8290895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of fas ligand in uveal melanoma-induced liver damage.
    Repp AC; Mayhew ES; Howard K; Alizadeh H; Niederkorn JY
    Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):752-8. PubMed ID: 11760036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.
    Nanni P; Nicoletti G; Landuzzi L; Croci S; Murgo A; Palladini A; Antognoli A; Ianzano ML; Stivani V; Grosso V; Maira SM; García-Echeverría C; Scotlandi K; De Giovanni C; Lollini PL
    Eur J Cancer; 2010 Feb; 46(3):659-68. PubMed ID: 20031388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Culture medium induced morphological changes of melanoma cells associated with change in sensitivity to lysis by lymphokine-activated killer cells.
    Perng YP; Lin CC; Perng IM; Shen YC; Chuang CK; Liao SK
    Cancer Biother Radiopharm; 1997 Oct; 12(5):317-31. PubMed ID: 10851482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.
    Blom DJ; Schurmans LR; De Waard-Siebinga I; De Wolff-Rouendaal D; Keunen JE; Jager MJ
    Br J Ophthalmol; 1997 Nov; 81(11):989-93. PubMed ID: 9505825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cells.
    Joshi P; Kooshki M; Aldrich W; Varghai D; Zborowski M; Singh AD; Triozzi PL
    Clin Exp Metastasis; 2016 Dec; 33(8):829-838. PubMed ID: 27565163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA expression in uveal melanoma: there is no rule without some exception.
    Jager MJ; Hurks HM; Levitskaya J; Kiessling R
    Hum Immunol; 2002 Jun; 63(6):444-51. PubMed ID: 12039519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.
    Balsamo M; Vermi W; Parodi M; Pietra G; Manzini C; Queirolo P; Lonardi S; Augugliaro R; Moretta A; Facchetti F; Moretta L; Mingari MC; Vitale M
    Eur J Immunol; 2012 Jul; 42(7):1833-42. PubMed ID: 22585684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Major histocompatibility antigens and antigen-processing molecules in uveal melanoma.
    Krishnakumar S; Abhyankar D; Sundaram AL; Pushparaj V; Shanmugam MP; Biswas J
    Clin Cancer Res; 2003 Sep; 9(11):4159-64. PubMed ID: 14519640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistance to NK cell-mediated cytotoxicity (in K-562 cells) does not correlate with class I MHC antigen levels.
    Reiter Z; Reiter Y; Fishelson Z; Shinitzky M; Kessler A; Loyter A; Nussbaum O; Rubinstein M
    Immunobiology; 1991 Sep; 183(1-2):23-39. PubMed ID: 1657763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of hyperthermia on expression of histocompatibility antigens and heat-shock protein molecules on three human ocular melanoma cell lines.
    Blom DJ; De Waard-Siebinga I; Apte RS; Luyten GP; Niederkorn JY; Jager MJ
    Melanoma Res; 1997 Apr; 7(2):103-9. PubMed ID: 9167175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth and Metastasis of Intraocular Tumors in Aged Mice.
    Han Z; Brown JR; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2366-76. PubMed ID: 27138736
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.
    Pietra G; Manzini C; Rivara S; Vitale M; Cantoni C; Petretto A; Balsamo M; Conte R; Benelli R; Minghelli S; Solari N; Gualco M; Queirolo P; Moretta L; Mingari MC
    Cancer Res; 2012 Mar; 72(6):1407-15. PubMed ID: 22258454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells.
    Placke T; Örgel M; Schaller M; Jung G; Rammensee HG; Kopp HG; Salih HR
    Cancer Res; 2012 Jan; 72(2):440-8. PubMed ID: 22127925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.